Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

IRIX

+ Watchlist+ Portfolio

IRIDEX Corp.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.70
52-Week Range
$0.47 – $1.65
Market Cap
$8.90M
P/E (TTM)
—
EPS (TTM)
-0.19
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
0.94
Return on Equity
-92.36%
Return on Assets
-5.49%
Gross Margin
38.21%
Operating Margin
-5.14%
Profit Margin
-6.85%
Current Ratio
1.76
Debt/Equity
2.83
Total Debt
$7.43M
Free Cash Flow
—
Revenue Growth
-18.60%
Earnings Growth
—
Enterprise Value
$18.56M

Market Snapshot

About

IRIDEX Corporation is a medical technology company that designs, develops, and manufactures ophthalmology laser systems and delivery devices. The company's products are used to treat a range of eye diseases including diabetic retinopathy, glaucoma, and retinal tears. IRIDEX's portfolio includes semiconductor-based laser consoles, delivery devices, and consumables used by ophthalmologists in clinical and surgical settings. The company focuses on developing innovative laser-based treatments that provide effective, minimally invasive therapeutic options for retinal and glaucoma patients worldwide.